Skip to content
Search

Latest Stories

Study reveals HCP concerns about UK’s ability to self-care

Nearly half of all healthcare professionals (HCPs) have concerns about the UK's ability in self-care, a study by the pharmaceutical company Perrigo has revealed.

This view is also shared by almost 63 per cent of NHS hospital-based HCPs.


The research, commissioned by the global self-care company, noted that lack of understanding could be responsible for self-care inability, it said.

The study, covering 203 UK pharmacists and general practitioners, focused on how a lack of awareness about self-care and personal wellbeing can lead to mental health issues. It can even lead to several other lifestyle-related issues such as sleep and diet.

In the research, HCPs informed that most patients in the UK suffer from stress related to work, financial issue and the pandemic, making them sleep deprived.

It noted a 76 per cent increase in mental health related queries during the past 12 months.

Alongside Perrigo’s research, PAGB released a study on change in people’s attitude towards self-care during the pandemic.

Speaking about the survey findings, Farah Ali, chief superintendent pharmacist at Warman-Freed Learning Pharmacy, said: “Self-care is relevant to every aspect of a patient’s health and wellbeing.”

“It’s easy for patients to compartmentalise minor health issues and to view them in isolation. However, patients often underestimate how much of an impact common ailments, such as headaches, hayfever, sore joints or a cough, can have on our mental health, sleep quality, diet and wider wellbeing,” she said.

Since pharmacists and GPs are experts on self-care, they can guide people through to the the benefits of good self-care practices, she added.

“For patients coming into pharmacy and complaining of minor ailments, pharmacists could gently engage with a simple question around their self-care practices. This opens up a dialogue and encourages the patients to think about their self-care habits,” Ali said.

Laure de Brauer, senior marketing director at Perrigo UK&I, said that consumers seem to be increasingly curious about self-care, but the UK's views still lag behind other European countries.

“As a nation, we need to do more to educate people about preventing illness, proactively  protecting their health, and managing minor ailments so they don't escalate, and in turn, boosting overall wellbeing,” she said.

Perrigo remains committed to supporting patients’ ability to self-care and to empower them to better-manage minor ailments through the use of its branded and retailer-branded products, Brauer said.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less